# EDGAR Filing Document

**Accession Number:** 0001432353
**File Stem:** 0001752724-23-016619
**Filing Date:** 2023-1
**Character Count:** 19198
**Document Hash:** d2e3f1d7e0f013ba8f98f92881dc2337
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-016619.hdr.sgml**: 20230127

**ACCESSION NUMBER**: 0001752724-23-016619

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221130

**FILED AS OF DATE**: 20230127

**DATE AS OF CHANGE**: 20230127

**PERIOD START**: 20221130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Global X Funds
- **CENTRAL INDEX KEY:** 0001432353
- **IRS NUMBER:** 000000000

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22209
- **FILM NUMBER:** 23562805

**BUSINESS ADDRESS:**
- **STREET 1:** 605 THIRD AVENUE
- **STREET 2:** 43RD FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10158
- **BUSINESS PHONE:** (212) 644-6110

**MAIL ADDRESS:**
- **STREET 1:** 605 THIRD AVENUE
- **STREET 2:** 43RD FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10158

## Series and Classes Contracts Data

### Global X Genomics & Biotechnology ETF (Series ID: S000062676)

| Class ID   | Class Name                            | Ticker Symbol   |
|:---|:---|:---|
| C000203266 | Global X Genomics & Biotechnology ETF | GNOM            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** GLOBAL X FUNDS

- **b. Investment Company Act file number:** 811-22209

- **c. CIK number of Registrant:** 0001432353

- **d. LEI of Registrant:** 5493003RA4QUTSYF1N15

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 605 Third Avenue

  - **City:** NEW YORK

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10158

  - **Telephone number:** 2126446110

**Item A.2. Information about the Series.**

- **a. Name of Series:** Global X Genomics & Biotechnology ETF

- **b. EDGAR series identifier (if any):** S000062676

- **c. LEI of Series:** 549300YI350KRC1BQK73

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2022-11-30

- **b. Date as of which information is reported:** 2022-11-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $209499886.95

**Total Liabilities:** $159152.89

**Net Assets:** $209340734.06

**Cash Not Reported:** $1.72

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000203266 | 2.36%                | 4.95%                | -9.67%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-40620195.83            | $45631858.11                               |
| Month 2  | $1117928.81              | $8907870.97                                |
| Month 3  | $1164091.58              | $-22893075.60                              |

### Schedule of Portfolio Investments

| Name                                                                               | Title                                          | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| TAKARA BIO INC.                                                                    | TAKARA BIO INC COMMON STOCK                    | CUSIP: N/A<br>LEI: 529900OUPLSGTCWC5447       | Long             | EC               |  | JP        |    155743 | NS      | $2010127.15   | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| ALNYLAM PHARMACEUTICALS, INC.                                                      | ALNYLAM PHARMACEUTICALS INC COMMON STOCK       | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               |  | US        |     39979 | NS      | $8818967.61   | 4.21%             |  |  |  | No            |                  1 | On Loan: No      |
| NATERA, INC.                                                                       | NATERA INC COMMON STOCK                        | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               |  | US        |    173455 | NS      | $7132469.60   | 3.41%             |  |  |  | No            |                  1 | On Loan: No      |
| VERTEX PHARMACEUTICALS INCORPORATED                                                | VERTEX PHARMACEUTICALS INC COMMON STOCK        | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               |  | US        |     12909 | NS      | $4084407.60   | 1.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Veracyte Inc                                                                       | VERACYTE INC COMMON STOCK                      | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               |  | US        |    239827 | NS      | $6652800.98   | 3.18%             |  |  |  | No            |                  1 | On Loan: No      |
| CAREDX, INC.                                                                       | CAREDX INC COMMON STOCK                        | CUSIP: 14167L103<br>LEI: 549300NQOFKL9NON0U06 | Long             | EC               |  | US        |    177318 | NS      | $2296268.10   | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| BioNTech SE                                                                        | BIONTECH SE-ADR DEPOSITARY RECEIPT             | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               |  | US        |     58630 | NS      | $9792382.60   | 4.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Caribou Biosciences Inc                                                            | CARIBOU BIOSCIENCES INC COMMON STOCK           | CUSIP: 142038108<br>LEI: N/A                  | Long             | EC               |  | US        |    171939 | NS      | $1600752.09   | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| NANOSTRING TECHNOLOGIES, INC.                                                      | NANOSTRING TECHNOLOGIES INC COMMON STOCK       | CUSIP: 63009R109<br>LEI: 549300G4CK0Y3WRDMY89 | Long             | EC               |  | US        |    155926 | NS      | $1089922.74   | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| SORRENTO THERAPEUTICS, INC.                                                        | SORRENTO THERAPEUTICS INC COMMON STOCK         | CUSIP: 83587F202<br>LEI: 549300RH23PRR3M13410 | Long             | EC               |  | US        |   1503283 | NS      | $1954267.90   | 0.93%             |  |  |  | No            |                  1 | On Loan: —       |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.                                            | PACIFIC BIOSCIENCES OF CALIF COMMON STOCK      | CUSIP: 69404D108<br>LEI: 529900F1BWRE1M0KZN89 | Long             | EC               |  | US        |    689506 | NS      | $7412189.50   | 3.54%             |  |  |  | No            |                  1 | On Loan: No      |
| ARROWHEAD PHARMACEUTICALS, INC.                                                    | ARROWHEAD PHARMACEUTICALS IN COMMON STOCK      | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               |  | US        |    245354 | NS      | $7900398.80   | 3.77%             |  |  |  | No            |                  1 | On Loan: No      |
| BIO-TECHNE CORPORATION                                                             | BIO-TECHNE CORP COMMON STOCK                   | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               |  | US        |    106516 | NS      | $9052794.84   | 4.32%             |  |  |  | No            |                  1 | On Loan: No      |
| MODERNA, INC.                                                                      | MODERNA INC COMMON STOCK                       | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               |  | US        |     28287 | NS      | $4975966.17   | 2.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Fulgent Genetics Inc                                                               | FULGENT GENETICS INC COMMON STOCK              | CUSIP: 359664109<br>LEI: 549300CL6P01M68QJ404 | Long             | EC               |  | US        |     70258 | NS      | $2548257.66   | 1.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Stoke Therapeutics Inc                                                             | STOKE THERAPEUTICS INC COMMON STOCK            | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               |  | US        |     73547 | NS      | $554544.38    | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| BLUEBIRD BIO, INC.                                                                 | BLUEBIRD BIO INC COMMON STOCK                  | CUSIP: 09609G100<br>LEI: N/A                  | Long             | EC               |  | US        |    256321 | NS      | $1996740.59   | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| U.S. DOLLARS                                                                       | FX Forward Contract: USD/EUR SETTLE 2022-12-01 | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $290.83       | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| INVITAE CORPORATION                                                                | INVITAE CORP COMMON STOCK                      | CUSIP: 46185L103<br>LEI: 549300MYI59DZW1WIX92 | Long             | EC               |  | US        |    782049 | NS      | $2322685.53   | 1.11%             |  |  |  | No            |                  1 | On Loan: —       |
| EDITAS MEDICINE, INC.                                                              | EDITAS MEDICINE INC COMMON STOCK               | CUSIP: 28106W103<br>LEI: 5299000AON4Q9NT2JE42 | Long             | EC               |  | US        |    231918 | NS      | $2458330.80   | 1.17%             |  |  |  | No            |                  1 | On Loan: No      |
| INTELLIA THERAPEUTICS, INC.                                                        | INTELLIA THERAPEUTICS INC COMMON STOCK         | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               |  | US        |    152929 | NS      | $7869726.34   | 3.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Genscript Biotech Corp                                                             | GENSCRIPT BIOTECH CORP COMMON STOCK            | CUSIP: N/A<br>LEI: 529900YIYUOJOXSAE372       | Long             | EC               |  | HK        |   3036018 | NS      | $7685826.11   | 3.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Beam Therapeutics Inc                                                              | BEAM THERAPEUTICS INC COMMON STOCK             | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               |  | US        |    169009 | NS      | $7806525.71   | 3.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Regenxbio Inc                                                                      | REGENXBIO INC COMMON STOCK                     | CUSIP: 75901B107<br>LEI: 549300EOES47LATSET33 | Long             | EC               |  | US        |    132657 | NS      | $3170502.30   | 1.51%             |  |  |  | No            |                  1 | On Loan: No      |
| AGILENT TECHNOLOGIES, INC.                                                         | AGILENT TECHNOLOGIES INC COMMON STOCK          | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               |  | US        |     58367 | NS      | $9045717.66   | 4.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Qiagen N.V.                                                                        | QIAGEN N.V. COMMON STOCK                       | CUSIP: N72482123<br>LEI: 54930036WK3GMCN17Z57 | Long             | EC               |  | US        |    180920 | NS      | $8962776.80   | 4.28%             |  |  |  | No            |                  1 | On Loan: No      |
| SANGAMO THERAPEUTICS, INC.                                                         | SANGAMO THERAPEUTICS INC COMMON STOCK          | CUSIP: 800677106<br>LEI: 2549006WMRKRC4G32Z67 | Long             | EC               |  | US        |    447213 | NS      | $1636799.58   | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| ILLUMINA, INC.                                                                     | ILLUMINA INC COMMON STOCK                      | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               |  | US        |     33860 | NS      | $7384188.80   | 3.53%             |  |  |  | No            |                  1 | On Loan: No      |
| GILEAD SCIENCES, INC.                                                              | GILEAD SCIENCES INC COMMON STOCK               | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               |  | US        |     56695 | NS      | $4979521.85   | 2.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Uniqure NV                                                                         | UNIQURE NV COMMON STOCK                        | CUSIP: N90064101<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               |  | US        |    141326 | NS      | $3739485.96   | 1.79%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG                                                             | CRISPR THERAPEUTICS AG COMMON STOCK            | CUSIP: H17182108<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               |  | US        |    145596 | NS      | $7977204.84   | 3.81%             |  |  |  | No            |                  1 | On Loan: No      |
| 2Seventy Bio Inc                                                                   | 2SEVENTY BIO INC COMMON STOCK                  | CUSIP: 901384107<br>LEI: N/A                  | Long             | EC               |  | US        |    119000 | NS      | $1864730.00   | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| MYRIAD GENETICS, INC.                                                              | MYRIAD GENETICS INC COMMON STOCK               | CUSIP: 62855J104<br>LEI: 52990044IHUOUMETT163 | Long             | EC               |  | US        |    262671 | NS      | $5321714.46   | 2.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Allogene Therapeutics Inc                                                          | ALLOGENE THERAPEUTICS INC COMMON STOCK         | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               |  | US        |    266829 | NS      | $2630933.94   | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| BIOMARIN PHARMACEUTICAL INC.                                                       | BIOMARIN PHARMACEUTICAL INC COMMON STOCK       | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               |  | US        |     87264 | NS      | $8811918.72   | 4.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Bionano Genomics Inc                                                               | BIONANO GENOMICS INC COMMON STOCK              | CUSIP: 09075F107<br>LEI: 54930086AP7ROH0VJ631 | Long             | EC               |  | US        |    965682 | NS      | $1941020.82   | 0.93%             |  |  |  | No            |                  1 | On Loan: —       |
| CureVac N.V.                                                                       | CUREVAC NV COMMON STOCK                        | CUSIP: N/A<br>LEI: 724500BUT8GAG9LMYN56       | Long             | EC               |  | DE        |     31858 | NS      | $224665.82    | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Fidelity Colchester Street Trust: Government Portfolio; Institutional Class Shares | Fidelity Money Market Government Portfolio     | CUSIP: 31607A703<br>LEI: N/A                  | Long             | STIV             |  | US        |   1083515 | PA      | $1083515.12   | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Verve Therapeutics Inc                                                             | VERVE THERAPEUTICS INC COMMON STOCK            | CUSIP: 92539P101<br>LEI: N/A                  | Long             | EC               |  | US        |    122986 | NS      | $2856964.78   | 1.36%             |  |  |  | No            |                  1 | On Loan: No      |
| 10X Genomics Inc                                                                   | 10X GENOMICS INC-CLASS A COMMON STOCK          | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               |  | US        |    289080 | NS      | $11175832.80  | 5.34%             |  |  |  | No            |                  1 | On Loan: No      |
| SAREPTA THERAPEUTICS, INC.                                                         | SAREPTA THERAPEUTICS INC COMMON STOCK          | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               |  | US        |     70313 | NS      | $8635139.53   | 4.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc                                                      | ULTRAGENYX PHARMACEUTICAL IN COMMON STOCK      | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               |  | US        |    201076 | NS      | $7299058.80   | 3.49%             |  |  |  | No            |                  1 | On Loan: No      |
| ROCKET PHARMACEUTICALS, INC.                                                       | ROCKET PHARMACEUTICALS INC COMMON STOCK        | CUSIP: 77313F106<br>LEI: 549300R7VV82YUIN4Y93 | Long             | EC               |  | US        |    208070 | NS      | $3928361.60   | 1.88%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2022-11-30

**Name of Applicant:** GLOBAL X FUNDS

**Signature:** Luis Berruga

**Name of Signer:** Luis Berruga

**Title:** President